by | Aug 9, 2022 | Publications
Case Rep Cardiol. 2022 Jul 30;2022:7846846. doi: 10.1155/2022/7846846. eCollection 2022. ABSTRACT We report a case of a 57-year-old woman with a history of multiple myeloma (MM) and light chain (AL) amyloidosis who presented due to worsening dyspnea on exertion. Her...
by | Aug 9, 2022 | Publications
Transplant Cell Ther. 2022 Aug 5:S2666-6367(22)01519-6. doi: 10.1016/j.jtct.2022.07.030. Online ahead of print. ABSTRACT BACKGROUND: High dose melphalan followed by autologous stem cell transplant (ASCT) remains the standard of care for transplant-eligible patients...
by | Aug 9, 2022 | Publications
Transplant Cell Ther. 2022 Aug 5:S2666-6367(22)01515-9. doi: 10.1016/j.jtct.2022.07.028. Online ahead of print. ABSTRACT BACKGROUND: Maintenance therapy with single-agent lenalidomide (Len) after autologous hematopoietic stem cell transplantation (autoHCT) for...
by | Aug 8, 2022 | Publications
Blood Adv. 2022 Aug 8:bloodadvances.2022008320. doi: 10.1182/bloodadvances.2022008320. Online ahead of print. ABSTRACT Idecabtagene vicleucel (ide-cel) was FDA approved in March 2021 for the treatment of relapsed/refractory multiple myeloma (RRMM) after 4 lines of...
by | Aug 8, 2022 | Publications
Hematology. 2022 Dec;27(1):847-852. doi: 10.1080/16078454.2022.2106818. ABSTRACT OBJECTIVE: The current diagnostic methods for multiple myeloma (MM) include bone marrow aspiration and biopsy, which are not only complicated but also invasive, causing great pain to...
by | Aug 8, 2022 | Publications
Contrast Media Mol Imaging. 2022 Jul 13;2022:7828230. doi: 10.1155/2022/7828230. eCollection 2022. ABSTRACT PURPOSE: To explore whether and why abnormal coagulation function and hemorrhage can appear in patients with hyperleukocytic acute myeloid leukemia (HAML)....
